Discussing the SURMOUNT-OSA phase 3 clinical trial of tirzepatide in patients with obstructive sleep apnea and obesity

Executed on:Aug 6, 2024 10:00 AM EDT

Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert

Institution: University of Miami Sleep Disorders Center

Board certified in Sleep Medicine and Neurology with Special Qualification in Child Neurology and the Medical Director of the Miami VA Healthcare system Sleep Disorders laboratory.
Areas of expertise include sleep disorders following traumatic brain injury, sleep disturbances, headaches, sleep apnea, snoring, insomnia and narcolepsy.
Clinicical research focus on sleep apnea and insomnia treatment adherence with an interest in the coexistence of sleep apnea and insomnia and how this complicates sleep disorders treatment.

Interview Goal

This call will feature a discussion on the current treatment landscape and the potential of tirzepatide for the treatment of obstructive sleep apnea and obesity along with an analysis of the SURMOUNT-OSA phase 3 clinical trial of tirzepatide.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.